ID

36456

Description

ICHOM Lung cancer data collection Version 2.3.1 Revised: April 10th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ For Lung Cancer, the following conditions and treatment approaches (or interventions) are covered by our Standard Set. Conditions: Small Cell and Non-Small Cell Lung Cancer Treatment Approaches: Surgery | Radiotherapy | Chemotherapy | Targeted Therapy | Immunotherapy | Other This document contains Follow-up - Clinical Form. It includes different points in time: After treatment, After surgery, Update at least annually, 1 year post initiation of treatment and Tracked ongoing annually for life (when hospital is able to track this ongoing). Collecting Patient-Reported Outcome Measures: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). European Organization for Research and Treatment of Cancer Quality of Life Lung Cancer-Specific Questionnaire (EORTC QLQ-LC13). Both are free for all health care organizations, but a license is needed for use. http:// groups.eortc.be/qol/eortc-qlq-c30 is the official distribution site for EORTC QLQ-C30 and EORTC QLQ-LC13 questionnaires. Therefore only the total score will be included in this version of the standard set. Publication: Mak KS, van Bommel AC, Stowell C, et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J. 2016;48(3):852–860. doi:10.1183/13993003.02049-2015

Lien

http://www.ichom.org/

Mots-clés

Versions (5)
  1. 15/05/2019 15/05/2019 -
  2. 20/05/2019 20/05/2019 -
  3. 30/04/2020 30/04/2020 - Sarah Riepenhausen
  4. 13/04/2021 13/04/2021 - Dr. rer. medic Philipp Neuhaus
  5. 20/09/2021 20/09/2021 -
Détendeur de droits

ICHOM

Téléchargé le

15 mai 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

ICHOM Lung Cancer

Anglais

Follow-up - Clinical Form

1 Formulaires  
Administrative data
Description

Administrative data

Alias
UMLS CUI-1
C1320722
Patient ID
Description

Supporting Definition: This number will not be shared with ICHOM. In the case patient-­‐level data is submitted to ICHOM for benchmarking or research purposes, a separate ICHOM Patient Identifier will be created and cross-­linking between the ICHOM Patient Identifier and the medical record number will only be known at the treating institution Inclusion Criteria: All patients Timing: On all forms Data Source: Administrative or clinical Type: Numerical Response Options: According to institution

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Time Relative to Baseline (e.g. After treatment, After surgery, Update at least annually, 1 year post initiation of treatment and Tracked ongoing annually for life (when hospital is able to track this ongoing).
Description

This Item does not exist in the original standard set, instead it is asked to do the following: Please timestamp all variables. Some Standard Set variables are collected at multiple timepoints, and we will ask you to submit these variables in a concatenated VARIABLEID_TIMESTAMP form for future analyses. For example, VARIABLEID_AT (After treatment); VARIABLEID_AS (After surgery); VARIABLEID_UPDATE (Update at least annually), etc.

Type de données

text

Alias
UMLS CUI [1,1]
C0439564
UMLS CUI [1,2]
C1442488
Degree of health
Description

Degree of health

Alias
UMLS CUI-1
C0018759
Q1 Perform: Change definition: Indicate the ECOG/WHO performance status
Description

Supporting Definition: ECOG / WHO scale: -­‐ PS = 0 normal activity level; -­‐ PS = 1 restricted with strenuous activity, but can do light activity; -­‐ PS = 2 active >/= 50% of day; -­‐ PS = 3 spends >50% of day in chair or bed; -­‐ PS = 4 totally confined to bed Inclusion Criteria: All patients Timing: Baseline 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C1520224
Baseline tumor factors
Description

Baseline tumor factors

Alias
UMLS CUI-1
C0475752
UMLS CUI-2
C1442488
Indicate the pathological tumor stage (per UICC / IASLC / AJCC 7th)
Description

Supporting Definition: Pathologic staging preferred, if available pT0: no primary tumor pT1: if not able to select T1a or T1b: Tumor ≤3 cm diameter, surrounded by lung or visceral pleura, without invasion more proximal than lobar bronchus pT1a: Tumor ≤2 cm in diameter pT1b: Tumor >2 cm but ≤3 cm in diameter pT2: if not able to select T2a or T2b: Tumor >3 cm but ≤7 cm, or tumor with any of the following features: Involves main bronchus, ≥2 cm distal to carina. Invades visceral pleura. Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung pT2a: Tumor >3 cm but ≤5 cm pT2b: Tumor >5 cm but ≤7 cm pT3: Tumor >7 cm or any of the following: Directly invades any of the following: chest wall, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium, main bronchus <2 cm from carina (without involvement of carina), Atelectasis or obstructive pneumonitis of the entire lung. Separate tumor nodules in the same lobe pT4: Tumor of any size that invades the mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, or with separate tumor nodules in a different ipsilateral lobe pTX: Primary tumor cannot be assessed Inclusion Criteria: All patients Timing: After surgery Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C1300072
UMLS CUI [1,2]
C1521733
Indicate the pathological nodal stage (per UICC / IASLC / AJCC 7th)
Description

Supporting Definition: Pathologic staging preferred, if available pN0: No regional lymph node metastases pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) pNX: Regional lymph nodes were not assessed Inclusion Criteria: All patients Timing: After surgery Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C0456532
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C0205469
Treatment Factors
Description

Treatment Factors

Alias
UMLS CUI-1
C0679853
Indicate if the patient completed treatment
Description

Inclusion Criteria: All patients Timing: After treatment Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C0580352
Treatment Variables
Description

Treatment Variables

Alias
UMLS CUI-1
C0087111
Indicate if the patient received surgery
Description

Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C0543467
Indicate date patient received surgery
Description

Inclusion Criteria: All patients If answered 'yes' on surgery (SURGERY) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1]
C1624150
DD/MM/YYYY
Indicate if the patient received targeted therapy
Description

Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C2985566
Indicate date patient started with targeted therapy
Description

Inclusion Criteria: All patients If answered 'yes' on targeted therapy (TARGETTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C3173309
DD/MM/YYYY
Indicate date patient stopped targeted therapy
Description

Inclusion Criteria: All patients If answered 'yes' on targeted therapy (TARGETTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C1531784
DD/MM/YYYY
Indicate if targeted therapy is ongoing
Description

Inclusion Criteria: All patients If answered 'yes' on targeted therapy (TARGETTX), and no end date is entered (TARGETTXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C0549178
Indicate if the patient received chemotherapy
Description

Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C0392920
Indicate date patient started with chemotherapy
Description

Inclusion Criteria: All patients If answered 'yes' on chemotherapy (CTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0808070
DD/MM/YYYY
Indicate date patient stopped with chemotherapy
Description

Inclusion Criteria: All patients If answered 'yes' on chemotherapy (CTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if chemotherapy is ongoing
Description

Inclusion Criteria: All patients If answered 'yes' on chemotherapy (CTX), and no end date is entered (CTXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C0549178
UMLS CUI [1,2]
C0392920
Indicate if the patient received immunotherapy
Description

Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C0021083
Indicate date patient started with immunotherapy
Description

Inclusion Criteria: All patients If answered 'yes' on immunotherapy (ITX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0808070
DD/MM/YYYY
Indicate date patient stopped with immunotherapy
Description

Inclusion Criteria: All patients If answered 'yes' on immunotherapy (ITX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if immunotherapy is ongoing
Description

Inclusion Criteria: All patients If answered 'yes' on immunotherapy (ITX), and no end date is entered (ITXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0549178
Indicate if the patient received radiotherapy
Description

Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C1522449
Indicate date patient started with radiotherapy
Description

Inclusion Criteria: All patients If answered 'yes' on radiotherapy (RTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1522449
DD/MM/YYYY
Indicate date patient stopped with radiotherapy
Description

Inclusion Criteria: All patients If answered 'yes' on radiotherapy (RTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0806020
DD/MM/YYYY
Indicate if radiotherapy is ongoing
Description

Inclusion Criteria: All patients If answered 'yes' on radiotherapy (RTX), and no end date is entered (RTXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0549178
Acute complications of treatment
Description

Acute complications of treatment

Alias
UMLS CUI-1
C0679861
Indicate if patient experienced a Clavien-Dindo grade III-IV complication within 6 months after initiating treatment
Description

Supporting Definition: Grade III: Requiring surgical, endoscopic, or radiological intervention, with our without general anesthesia Grade IV: Life threatening complication (including CNS complications) requiring IC/ICU management; includes single organ dysfunction and multiorgan dysfunction Source: Annals of Surgery. 250(2):187-­196, August 2009. Inclusion Criteria: All patients receiving resectional surgery If answered 'yes' on surgery (SURGERY) Timing: Update at least annually Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1,1]
C4055231
UMLS CUI [1,2]
C0032787
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 0 = No grade III-IV toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C1298908
UMLS CUI [2,3]
C0013221
UMLS CUI [2,4]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 1 = Cytopenias (anemia, febrile neutropenia, thrombocytopenia)
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0010828
UMLS CUI [2,3]
C1522449
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0002871
UMLS CUI [3,3]
C1522449
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C0746883
UMLS CUI [4,3]
C1522449
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0040034
UMLS CUI [5,3]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 2 = Infection, any primary site
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0009450
UMLS CUI [2,3]
C0475447
UMLS CUI [2,4]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 3 = Skin reaction (rash, dermatitis radiation)
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0015230
UMLS CUI [2,3]
C1522449
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0034561
UMLS CUI [3,3]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 4 = Pneumonitis, cough, dyspnea, other lung toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C3714636
UMLS CUI [2,3]
C1522449
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0010200
UMLS CUI [3,3]
C1522449
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C0013404
UMLS CUI [4,3]
C1522449
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0205394
UMLS CUI [5,3]
C0024109
UMLS CUI [5,4]
C0040539
UMLS CUI [5,5]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 5 = Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0014868
UMLS CUI [2,3]
C1522449
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C1568868
UMLS CUI [3,3]
C1522449
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C0027497
UMLS CUI [4,3]
C1522449
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0042963
UMLS CUI [5,3]
C1522449
UMLS CUI [6,1]
C0009566
UMLS CUI [6,2]
C0011991
UMLS CUI [6,3]
C1522449
UMLS CUI [7,1]
C0009566
UMLS CUI [7,2]
C0009806
UMLS CUI [7,3]
C1522449
UMLS CUI [8,1]
C0009566
UMLS CUI [8,2]
C0205394
UMLS CUI [8,3]
C0521362
UMLS CUI [8,4]
C0600688
UMLS CUI [8,5]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 6 = Neuropathy, tinnitus, hearing impaired, other neurologic toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0442874
UMLS CUI [2,3]
C1522449
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0040264
UMLS CUI [3,3]
C1522449
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C1384666
UMLS CUI [4,3]
C1522449
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0205394
UMLS CUI [5,3]
C0205494
UMLS CUI [5,4]
C0600688
UMLS CUI [5,5]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 7 = Acute kidney injury
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C2609414
UMLS CUI [2,3]
C1522449
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 888 = Other
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-­06-­14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0205394
UMLS CUI [2,3]
C1522449
Indicate the CTCAE v 4.0 grade III-IV complication the patient experienced
Description

Inclusion Criteria: Patients with radiotherapy If answered 'Other' on CTCAE III­‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Free text Response Options: CTCAE grade III-­‐IV complication due to radiotherapy

Type de données

text

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1516728
UMLS CUI [1,3]
C1522449
UMLS CUI [1,4]
C0205394
Indicate date of cytopenias
Description

Inclusion Criteria: Patients with radiotherapy If answered Cytopenias on CTCAE III-‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0010828
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of infection
Description

Inclusion Criteria: Patients with radiotherapy If answered Infection on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of skin reaction
Description

Inclusion Criteria: Patients with radiotherapy If answered Skin reaction on CTCAE III­‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0221743
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of pneumonitis, cough, dyspnea, or other lung toxicity
Description

Inclusion Criteria: Patients with radiotherapy If answered Pneumonitis, cough, dyspnea, other lung toxicity on CTCAE III­‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C3714636
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0010200
UMLS CUI [3,1]
C0011008
UMLS CUI [3,2]
C0013404
UMLS CUI [4,1]
C0011008
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0024109
UMLS CUI [4,4]
C0040539
DD/MM/YYYY
Indicate date of oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, or other GI toxicity
Description

Inclusion Criteria: Patients with radiotherapy If answered Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0014868
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C1568868
UMLS CUI [3,1]
C0011008
UMLS CUI [3,2]
C0027497
UMLS CUI [4,1]
C0011008
UMLS CUI [4,2]
C0042963
UMLS CUI [5,1]
C0011008
UMLS CUI [5,2]
C0011991
UMLS CUI [6,1]
C0011008
UMLS CUI [6,2]
C0009806
UMLS CUI [7,1]
C0011008
UMLS CUI [7,2]
C0205394
UMLS CUI [7,3]
C0521362
UMLS CUI [7,4]
C0600688
DD/MM/YYYY
Indicate date of neuropathy, tinnitus, hearing impaired, or other neurologic toxicity
Description

Inclusion Criteria: Patients with radiotherapy If answered Neuropathy, tinnitus, hearing impaired, other neurologic toxicity on CTCAE III-­IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0442874
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0040264
UMLS CUI [3,1]
C0011008
UMLS CUI [3,2]
C1384666
UMLS CUI [4,1]
C0011008
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0205494
UMLS CUI [4,4]
C0600688
DD/MM/YYYY
Indicate date of acute kidney injury
Description

Inclusion Criteria: Patients with radiotherapy If answered Acute kidney injury on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2609414
DD/MM/YYYY
Indicate date of other complication
Description

Inclusion Criteria: Patients with radiotherapy If answered Other on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0009566
UMLS CUI [1,3]
C0011008
DD/MM/YYYY
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 0 = No grade III-IV toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C1298908
UMLS CUI [2,3]
C0013221
UMLS CUI [2,4]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 1 = Cytopenias (anemia, febrile neutropenia, thrombocytopenia)
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0010828
UMLS CUI [2,3]
C1515119
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0002871
UMLS CUI [3,3]
C1515119
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C0746883
UMLS CUI [4,3]
C1515119
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0040034
UMLS CUI [5,3]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 2 = Infection, any primary site
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0009450
UMLS CUI [2,3]
C0475447
UMLS CUI [2,4]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 3 = Skin reaction (rash, dermatitis radiation)
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0015230
UMLS CUI [2,3]
C1515119
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0034561
UMLS CUI [3,3]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 4 = Pneumonitis, cough, dyspnea, other lung toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C3714636
UMLS CUI [2,3]
C1515119
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0010200
UMLS CUI [3,3]
C1515119
UMLS CUI [3,4]
|C0009566
UMLS CUI [3,5]
C0013404
UMLS CUI [3,6]
C1515119
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0024109
UMLS CUI [4,4]
C0040539
UMLS CUI [4,5]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 5 = Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0014868
UMLS CUI [2,3]
C1515119
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C1568868
UMLS CUI [3,3]
C1515119
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C0027497
UMLS CUI [4,3]
C1515119
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0042963
UMLS CUI [5,3]
C1515119
UMLS CUI [6,1]
C0009566
UMLS CUI [6,2]
C0011991
UMLS CUI [6,3]
C1515119
UMLS CUI [7,1]
C0009566
UMLS CUI [7,2]
C0009806
UMLS CUI [7,3]
C1515119
UMLS CUI [8,1]
C0009566
UMLS CUI [8,2]
C0205394
UMLS CUI [8,3]
C0521362
UMLS CUI [8,4]
C0600688
UMLS CUI [8,5]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 6 = Neuropathy, tinnitus, hearing impaired, other neurologic toxicity
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0442874
UMLS CUI [2,3]
C1515119
UMLS CUI [3,1]
C0009566
UMLS CUI [3,2]
C0040264
UMLS CUI [3,3]
C1515119
UMLS CUI [4,1]
C0009566
UMLS CUI [4,2]
C1384666
UMLS CUI [4,3]
C1515119
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0205394
UMLS CUI [5,3]
C0205494
UMLS CUI [5,4]
C0600688
UMLS CUI [5,5]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 7 = Acute kidney injury
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C2609414
UMLS CUI [2,3]
C1515119
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 888 = Other
Description

Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516728
UMLS CUI [1,2]
C1515119
UMLS CUI [2,1]
C0009566
UMLS CUI [2,2]
C0205394
UMLS CUI [2,3]
C1515119
Indicate the CTCAE v 4.0 grade III-IV complication the patient experienced
Description

Inclusion Criteria: Patients with systemic therapy If answered 'Other' on CTCAE III­‐IV complications due to systemic therapy (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Free text Response Options: CTCAE grade III-­IV complication due to systemic therapy

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0009566
UMLS CUI [1,3]
C1515119
UMLS CUI [1,4]
C1516728
Indicate date of cytopenias
Description

Inclusion Criteria: Patients with systemic therapy If answered Cytopenias on CTCAE grade II-­IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0010828
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of infection
Description

Inclusion Criteria: Patients with systemic therapy If answered Infection on CTCAE grade II-­IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of skin reaction
Description

Inclusion Criteria: Patients with systemic therapy If answered Skin reaction on CTCAE grade II-­IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0221743
UMLS CUI [1,2]
C0011008
DD/MM/YYYY
Indicate date of pneumonitis, cough, dyspnea, or other lung toxicity
Description

Inclusion Criteria: Patients with systemic therapy If answered Pneumonitis, cough, dyspnea, other lung toxicity on CTCAE grade II­‐IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C3714636
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0010200
UMLS CUI [3,1]
C0011008
UMLS CUI [3,2]
C0013404
UMLS CUI [4,1]
C0011008
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0024109
UMLS CUI [4,4]
C0040539
DD/MM/YYYY
Indicate date of oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, or other GI toxicity
Description

Inclusion Criteria: Patients with systemic therapy If answered Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity on CTCAE grade II‐IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0014868
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C1568868
UMLS CUI [3,1]
C0011008
UMLS CUI [3,2]
C0027497
UMLS CUI [4,1]
C0011008
UMLS CUI [4,2]
C0042963
UMLS CUI [5,1]
C0011008
UMLS CUI [5,2]
C0011991
UMLS CUI [6,1]
C0011008
UMLS CUI [6,2]
C0009806
UMLS CUI [7,1]
C0011008
UMLS CUI [7,2]
C0205394
UMLS CUI [7,3]
C0521362
UMLS CUI [7,4]
C0600688
DD/MM/YYYY
Indicate date of neuropathy, tinnitus, hearing impaired, or other neurologic toxicity
Description

Inclusion Criteria: Patients with systemic therapy If answered Neuropathy, tinnitus, hearing impaired, other neurologic toxicity on CTCAE grade II-­IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0442874
UMLS CUI [2,1]
C0011008
UMLS CUI [2,2]
C0040264
UMLS CUI [3,1]
C0011008
UMLS CUI [3,2]
C1384666
UMLS CUI [4,1]
C0011008
UMLS CUI [4,2]
C0205394
UMLS CUI [4,3]
C0205494
UMLS CUI [4,4]
C0600688
DD/MM/YYYY
Indicate date of acute kidney injury
Description

Inclusion Criteria: Patients with systemic therapy If answered Acute kidney injury on CTCAE grade II‐IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2609414
DD/MM/YYYY
Indicate date of other complication
Description

Inclusion Criteria: Patients with systemic therapy If answered Other on CTCAE grade II-­IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY

Type de données

date

Unités de mesure
  • DD/MM/YYYY
Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0009566
UMLS CUI [1,3]
C0011008
DD/MM/YYYY
Survival
Description

Survival

Alias
UMLS CUI-1
C1148433
Indicate if death is noted to be directly attributable to lung cancer as indicated on certificate of death
Description

Inclusion Criteria: All patients If answered "yes” on the question "indicate if the patient has died" (DEATH) Timing: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Administrative data (Death registry) or clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C0007465
UMLS CUI [2]
C0242379
Indicate if death was directly attributable to lung cancer treatment
Description

Supporting Definition: This is needed to calculate the 30 and 90 day treatment related mortality Inclusion Criteria: All patients receiving treatment If answered "yes” on the question "indicate if the patient has died" (DEATH) Timing: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Single answer

Type de données

integer

Alias
UMLS CUI [1]
C0007465
UMLS CUI [2,1]
C0242379
UMLS CUI [2,2]
C0920425
Quality of death
Description

Quality of death

Alias
UMLS CUI-1
C0011065
UMLS CUI-2
C0332306
Indicate how long patient spent time in the hospital (in hospital includes ICU) at end of life, meaning last 30 days
Description

Inclusion Criteria: All patients with end-­‐stage disease If answered 'yes' on overall survival (OVERALLSURV) Timing: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Numerical value Response Options: Numerical value of number of days

Type de données

integer

Alias
UMLS CUI [1]
C3694481
Retour au début de la page

Similar models

Follow-up - Clinical Form

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Patient ID
Item
Patient ID
integer
C2348585 (UMLS CUI [1])
Time Relative to Baseline
Item
Time Relative to Baseline (e.g. After treatment, After surgery, Update at least annually, 1 year post initiation of treatment and Tracked ongoing annually for life (when hospital is able to track this ongoing).
text
C0439564 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
Item Group
Degree of health
C0018759 (UMLS CUI-1)
Item
Q1 Perform: Change definition: Indicate the ECOG/WHO performance status
integer
C1520224 (UMLS CUI [1])
ECOG/WHO performance status
Code List
Q1 Perform: Change definition: Indicate the ECOG/WHO performance status
CL Item
0 (0)
C1828078 (UMLS CUI-1)
(Comment:en)
CL Item
1 (1)
C1827388 (UMLS CUI-1)
(Comment:en)
CL Item
2 (2)
C1828242 (UMLS CUI-1)
(Comment:en)
CL Item
3 (3)
C1827126 (UMLS CUI-1)
(Comment:en)
CL Item
4 (4)
C1827528 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
C1520224 (UMLS CUI-2)
(Comment:en)
Item Group
Baseline tumor factors
C0475752 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
Item
Indicate the pathological tumor stage (per UICC / IASLC / AJCC 7th)
integer
C1300072 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
Pathological tumor stage
Code List
Indicate the pathological tumor stage (per UICC / IASLC / AJCC 7th)
CL Item
pT0 (0)
C0332390 (UMLS CUI-1)
(Comment:en)
CL Item
pT1 (1)
C0332391 (UMLS CUI-1)
(Comment:en)
CL Item
pT1a (2)
C2733107 (UMLS CUI-1)
(Comment:en)
CL Item
pT1b (3)
C2733246 (UMLS CUI-1)
(Comment:en)
CL Item
pT2 (4)
C0332392 (UMLS CUI-1)
(Comment:en)
CL Item
pT2a (5)
C2732270 (UMLS CUI-1)
(Comment:en)
CL Item
pT2b (6)
C2733080 (UMLS CUI-1)
(Comment:en)
CL Item
pT3 (7)
C0332393 (UMLS CUI-1)
(Comment:en)
CL Item
pT4 (8)
C0332394 (UMLS CUI-1)
(Comment:en)
CL Item
pTX (9)
C0332395 (UMLS CUI-1)
C0205469 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
C1521733 (UMLS CUI-2)
C1300072 (UMLS CUI-3)
(Comment:en)
Item
Indicate the pathological nodal stage (per UICC / IASLC / AJCC 7th)
integer
C0456532 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C0205469 (UMLS CUI [1,3])
Pathological nodal stage
Code List
Indicate the pathological nodal stage (per UICC / IASLC / AJCC 7th)
CL Item
pN0 (0)
C0332396 (UMLS CUI-1)
(Comment:en)
CL Item
pN1 (1)
C0332397 (UMLS CUI-1)
(Comment:en)
CL Item
pN2 (2)
C0332398 (UMLS CUI-1)
(Comment:en)
CL Item
pN3 (3)
C0332399 (UMLS CUI-1)
(Comment:en)
CL Item
pNX (4)
C0332401 (UMLS CUI-1)
C1521733 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
C0456532 (UMLS CUI-2)
C1300072 (UMLS CUI-3)
C0205469 (UMLS CUI-4)
(Comment:en)
Item Group
Treatment Factors
C0679853 (UMLS CUI-1)
Item
Indicate if the patient completed treatment
integer
C0580352 (UMLS CUI [1])
Completed treatment
Code List
Indicate if the patient completed treatment
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
CL Item
Yes but with chemotherapy dose reduction (2)
C1705108 (UMLS CUI-1)
C3665472 (UMLS CUI-2)
C1707814 (UMLS CUI-3)
(Comment:en)
CL Item
Yes but with radiotherapy dose reduction (3)
C1705108 (UMLS CUI-1)
C1522449 (UMLS CUI-2)
C1707814 (UMLS CUI-3)
(Comment:en)
CL Item
No, patient choice (4)
C1298908 (UMLS CUI-1)
C3841966 (UMLS CUI-2)
(Comment:en)
CL Item
No, due to toxicity (5)
C1298908 (UMLS CUI-1)
C0600688 (UMLS CUI-2)
(Comment:en)
CL Item
No, due to patient death (6)
C1298908 (UMLS CUI-1)
C0011065 (UMLS CUI-2)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item Group
Treatment Variables
C0087111 (UMLS CUI-1)
Item
Indicate if the patient received surgery
integer
C0543467 (UMLS CUI [1])
Treatments received during the last year: Surgery
Code List
Indicate if the patient received surgery
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, primary tumor (1)
C1705108 (UMLS CUI-1)
C0677930 (UMLS CUI-2)
(Comment:en)
CL Item
Yes, any metastatic site except brain (2)
C1705108 (UMLS CUI-1)
C2939420 (UMLS CUI-2)
C0332300 (UMLS CUI-3)
C0220650 (UMLS CUI-4)
(Comment:en)
CL Item
Yes, brain metastasis (3)
C1705108 (UMLS CUI-1)
C0006104 (UMLS CUI-2)
C0027627 (UMLS CUI-3)
(Comment:en)
Date of surgery
Item
Indicate date patient received surgery
date
C1624150 (UMLS CUI [1])
Item
Indicate if the patient received targeted therapy
integer
C2985566 (UMLS CUI [1])
Treatments received during the last year: Targeted therapy
Code List
Indicate if the patient received targeted therapy
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
Start of targeted therapy
Item
Indicate date patient started with targeted therapy
date
C2985566 (UMLS CUI [1,1])
C3173309 (UMLS CUI [1,2])
Stop of targeted therapy
Item
Indicate date patient stopped targeted therapy
date
C2985566 (UMLS CUI [1,1])
C1531784 (UMLS CUI [1,2])
Item
Indicate if targeted therapy is ongoing
integer
C2985566 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing targeted therapy
Code List
Indicate if targeted therapy is ongoing
CL Item
Treatment ongoing (1)
C2985566 (UMLS CUI-1)
C0549178 (UMLS CUI-2)
(Comment:en)
Item
Indicate if the patient received chemotherapy
integer
C0392920 (UMLS CUI [1])
Treatments received during the last year: Targeted therapy
Code List
Indicate if the patient received chemotherapy
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
Start of chemotherapy
Item
Indicate date patient started with chemotherapy
date
C0392920 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Stop of chemotherapy
Item
Indicate date patient stopped with chemotherapy
date
C0392920 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if chemotherapy is ongoing
integer
C0549178 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Ongoing chemotherapy
Code List
Indicate if chemotherapy is ongoing
CL Item
Treatment ongoing (1)
C0549178 (UMLS CUI-1)
C0392920 (UMLS CUI-2)
(Comment:en)
Item
Indicate if the patient received immunotherapy
integer
C0021083 (UMLS CUI [1])
Treatments received during the last year: Chemotherapy
Code List
Indicate if the patient received immunotherapy
CL Item
No (0)
CL Item
Yes (1)
Start of immunotherapy
Item
Indicate date patient started with immunotherapy
date
C0021083 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Stop of immunotherapy
Item
Indicate date patient stopped with immunotherapy
date
C0021083 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if immunotherapy is ongoing
integer
C0021083 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing immunotherapy
Code List
Indicate if immunotherapy is ongoing
CL Item
Treatment ongoing (1)
C0021083 (UMLS CUI-1)
C0549178 (UMLS CUI-2)
(Comment:en)
Item
Indicate if the patient received radiotherapy
integer
C1522449 (UMLS CUI [1])
Treatments received during the last year: Surgery
Code List
Indicate if the patient received radiotherapy
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, primary tumor (1)
C1705108 (UMLS CUI-1)
C0677930 (UMLS CUI-2)
(Comment:en)
CL Item
Yes, any metastatic site except brain (2)
C1705108 (UMLS CUI-1)
C2939420 (UMLS CUI-2)
C0332300 (UMLS CUI-3)
C0220650 (UMLS CUI-4)
(Comment:en)
CL Item
Yes, brain metastasis (3)
C1705108 (UMLS CUI-1)
C0006104 (UMLS CUI-2)
C0027627 (UMLS CUI-3)
(Comment:en)
Start of radiotherapy
Item
Indicate date patient started with radiotherapy
date
C0808070 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
Stop of radiotherapy
Item
Indicate date patient stopped with radiotherapy
date
C1522449 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Indicate if radiotherapy is ongoing
integer
C1522449 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Ongoing radiotherapy
Code List
Indicate if radiotherapy is ongoing
CL Item
Treatment ongoing (1)
C1522449 (UMLS CUI-1)
C0549178 (UMLS CUI-2)
(Comment:en)
Item Group
Acute complications of treatment
C0679861 (UMLS CUI-1)
Item
Indicate if patient experienced a Clavien-Dindo grade III-IV complication within 6 months after initiating treatment
integer
C4055231 (UMLS CUI [1,1])
C0032787 (UMLS CUI [1,2])
Clavien-Dindo grade III-IV complications due to surgery
Code List
Indicate if patient experienced a Clavien-Dindo grade III-IV complication within 6 months after initiating treatment
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes, grade III (1)
C1705108 (UMLS CUI-1)
C4055231 (UMLS CUI-2)
C0450094 (UMLS CUI-3)
(Comment:en)
CL Item
Yes, grade IV (2)
C1705108 (UMLS CUI-1)
C4055231 (UMLS CUI-2)
C0547054 (UMLS CUI-3)
(Comment:en)
CTCAE grade III-IV complications due to radiotherapy: No grade III-IV toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 0 = No grade III-IV toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C1298908 (UMLS CUI [2,2])
C0013221 (UMLS CUI [2,3])
C1522449 (UMLS CUI [2,4])
CTCAE grade III-IV complications due to radiotherapy: Cytopenias
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 1 = Cytopenias (anemia, febrile neutropenia, thrombocytopenia)
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0010828 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0002871 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C0746883 (UMLS CUI [4,2])
C1522449 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0040034 (UMLS CUI [5,2])
C1522449 (UMLS CUI [5,3])
CTCAE grade III-IV complications due to radiotherapy: Infection
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 2 = Infection, any primary site
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
C0475447 (UMLS CUI [2,3])
C1522449 (UMLS CUI [2,4])
CTCAE grade III-IV complications due to radiotherapy: Skin reaction
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 3 = Skin reaction (rash, dermatitis radiation)
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0015230 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0034561 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
CTCAE grade III-IV complications due to radiotherapy: Pneumonitis, cough, dyspnea, other lung toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 4 = Pneumonitis, cough, dyspnea, other lung toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C3714636 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0010200 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C0013404 (UMLS CUI [4,2])
C1522449 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0205394 (UMLS CUI [5,2])
C0024109 (UMLS CUI [5,3])
C0040539 (UMLS CUI [5,4])
C1522449 (UMLS CUI [5,5])
CTCAE grade III-IV complications due to radiotherapy: Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 5 = Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0014868 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C1568868 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C0027497 (UMLS CUI [4,2])
C1522449 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0042963 (UMLS CUI [5,2])
C1522449 (UMLS CUI [5,3])
C0009566 (UMLS CUI [6,1])
C0011991 (UMLS CUI [6,2])
C1522449 (UMLS CUI [6,3])
C0009566 (UMLS CUI [7,1])
C0009806 (UMLS CUI [7,2])
C1522449 (UMLS CUI [7,3])
C0009566 (UMLS CUI [8,1])
C0205394 (UMLS CUI [8,2])
C0521362 (UMLS CUI [8,3])
C0600688 (UMLS CUI [8,4])
C1522449 (UMLS CUI [8,5])
CTCAE grade III-IV complications due to radiotherapy: Neuropathy, tinnitus, hearing impaired, other neurologic toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 6 = Neuropathy, tinnitus, hearing impaired, other neurologic toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0442874 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0040264 (UMLS CUI [3,2])
C1522449 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C1384666 (UMLS CUI [4,2])
C1522449 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0205394 (UMLS CUI [5,2])
C0205494 (UMLS CUI [5,3])
C0600688 (UMLS CUI [5,4])
C1522449 (UMLS CUI [5,5])
CTCAE grade III-IV complications due to radiotherapy: Acute kidney injury
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 7 = Acute kidney injury
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C2609414 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
CTCAE grade III-IV complications due to radiotherapy: Other
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-IV complication while on therapy and within 6 months after initiating treatment: 888 = Other
boolean
C1516728 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C1522449 (UMLS CUI [2,3])
CTCAE grade III-IV complication due to radiotherapy other than those explicitly listed
Item
Indicate the CTCAE v 4.0 grade III-IV complication the patient experienced
text
C0009566 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
Date of cytopenias
Item
Indicate date of cytopenias
date
C0010828 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of infection
Item
Indicate date of infection
date
C0009450 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of skin reaction
Item
Indicate date of skin reaction
date
C0221743 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of pneumonitis, cough, dyspnea, or other lung toxicity
Item
Indicate date of pneumonitis, cough, dyspnea, or other lung toxicity
date
C0011008 (UMLS CUI [1,1])
C3714636 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C0010200 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3,1])
C0013404 (UMLS CUI [3,2])
C0011008 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0024109 (UMLS CUI [4,3])
C0040539 (UMLS CUI [4,4])
Date of oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, or other GI toxicity
Item
Indicate date of oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, or other GI toxicity
date
C0011008 (UMLS CUI [1,1])
C0014868 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C1568868 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3,1])
C0027497 (UMLS CUI [3,2])
C0011008 (UMLS CUI [4,1])
C0042963 (UMLS CUI [4,2])
C0011008 (UMLS CUI [5,1])
C0011991 (UMLS CUI [5,2])
C0011008 (UMLS CUI [6,1])
C0009806 (UMLS CUI [6,2])
C0011008 (UMLS CUI [7,1])
C0205394 (UMLS CUI [7,2])
C0521362 (UMLS CUI [7,3])
C0600688 (UMLS CUI [7,4])
Date of neuropathy, tinnitus, hearing impaired, or other neurologic toxicity
Item
Indicate date of neuropathy, tinnitus, hearing impaired, or other neurologic toxicity
date
C0011008 (UMLS CUI [1,1])
C0442874 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C0040264 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3,1])
C1384666 (UMLS CUI [3,2])
C0011008 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0205494 (UMLS CUI [4,3])
C0600688 (UMLS CUI [4,4])
Date of acute kidney injury
Item
Indicate date of acute kidney injury
date
C0011008 (UMLS CUI [1,1])
C2609414 (UMLS CUI [1,2])
Date of other complication
Item
Indicate date of other complication
date
C0205394 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
CTCAE grade III-IV complications due to systemic therapy: No grade III-IV toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 0 = No grade III-IV toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C1298908 (UMLS CUI [2,2])
C0013221 (UMLS CUI [2,3])
C1515119 (UMLS CUI [2,4])
CTCAE grade III-IV complications due to systemic therapy: Cytopenias
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 1 = Cytopenias (anemia, febrile neutropenia, thrombocytopenia)
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0010828 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0002871 (UMLS CUI [3,2])
C1515119 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C0746883 (UMLS CUI [4,2])
C1515119 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0040034 (UMLS CUI [5,2])
C1515119 (UMLS CUI [5,3])
CTCAE grade III-IV complications due to systemic therapy: Infection
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 2 = Infection, any primary site
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
C0475447 (UMLS CUI [2,3])
C1515119 (UMLS CUI [2,4])
CTCAE grade III-IV complications due to systemic therapy: Skin reaction
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 3 = Skin reaction (rash, dermatitis radiation)
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0015230 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0034561 (UMLS CUI [3,2])
C1515119 (UMLS CUI [3,3])
CTCAE grade III-IV complications due to systemic therapy: Pneumonitis, cough, dyspnea, other lung toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 4 = Pneumonitis, cough, dyspnea, other lung toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C3714636 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0010200 (UMLS CUI [3,2])
C1515119 (UMLS CUI [3,3])
|C0009566 (UMLS CUI [3,4])
C0013404 (UMLS CUI [3,5])
C1515119 (UMLS CUI [3,6])
C0009566 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0024109 (UMLS CUI [4,3])
C0040539 (UMLS CUI [4,4])
C1515119 (UMLS CUI [4,5])
CTCAE grade III-IV complications due to systemic therapy: Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 5 = Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0014868 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C1568868 (UMLS CUI [3,2])
C1515119 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C0027497 (UMLS CUI [4,2])
C1515119 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0042963 (UMLS CUI [5,2])
C1515119 (UMLS CUI [5,3])
C0009566 (UMLS CUI [6,1])
C0011991 (UMLS CUI [6,2])
C1515119 (UMLS CUI [6,3])
C0009566 (UMLS CUI [7,1])
C0009806 (UMLS CUI [7,2])
C1515119 (UMLS CUI [7,3])
C0009566 (UMLS CUI [8,1])
C0205394 (UMLS CUI [8,2])
C0521362 (UMLS CUI [8,3])
C0600688 (UMLS CUI [8,4])
C1515119 (UMLS CUI [8,5])
CTCAE grade III-IV complications due to systemic therapy: Neuropathy, tinnitus, hearing impaired, other neurologic toxicity
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 6 = Neuropathy, tinnitus, hearing impaired, other neurologic toxicity
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0442874 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
C0009566 (UMLS CUI [3,1])
C0040264 (UMLS CUI [3,2])
C1515119 (UMLS CUI [3,3])
C0009566 (UMLS CUI [4,1])
C1384666 (UMLS CUI [4,2])
C1515119 (UMLS CUI [4,3])
C0009566 (UMLS CUI [5,1])
C0205394 (UMLS CUI [5,2])
C0205494 (UMLS CUI [5,3])
C0600688 (UMLS CUI [5,4])
C1515119 (UMLS CUI [5,5])
CTCAE grade III-IV complications due to systemic therapy: Acute kidney injury
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 7 = Acute kidney injury
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C2609414 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
CTCAE grade III-IV complications due to systemic therapy: Other
Item
Indicate if patient experienced a CTCAE v 4.0 grade III-V complication while on therapy and within 6 months after initiating treatment: 888 = Other
boolean
C1516728 (UMLS CUI [1,1])
C1515119 (UMLS CUI [1,2])
C0009566 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C1515119 (UMLS CUI [2,3])
CTCAE grade III-IV complication due to systemic therapy other than those explicitly listed
Item
Indicate the CTCAE v 4.0 grade III-IV complication the patient experienced
text
C0205394 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
Date of cytopenias
Item
Indicate date of cytopenias
date
C0010828 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of infection
Item
Indicate date of infection
date
C0009450 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of skin reaction
Item
Indicate date of skin reaction
date
C0221743 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Date of pneumonitis, cough, dyspnea, or other lung toxicity
Item
Indicate date of pneumonitis, cough, dyspnea, or other lung toxicity
date
C0011008 (UMLS CUI [1,1])
C3714636 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C0010200 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3,1])
C0013404 (UMLS CUI [3,2])
C0011008 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0024109 (UMLS CUI [4,3])
C0040539 (UMLS CUI [4,4])
Date of oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, or other GI toxicity
Item
Indicate date of oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, or other GI toxicity
date
C0011008 (UMLS CUI [1,1])
C0014868 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C1568868 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3,1])
C0027497 (UMLS CUI [3,2])
C0011008 (UMLS CUI [4,1])
C0042963 (UMLS CUI [4,2])
C0011008 (UMLS CUI [5,1])
C0011991 (UMLS CUI [5,2])
C0011008 (UMLS CUI [6,1])
C0009806 (UMLS CUI [6,2])
C0011008 (UMLS CUI [7,1])
C0205394 (UMLS CUI [7,2])
C0521362 (UMLS CUI [7,3])
C0600688 (UMLS CUI [7,4])
Date of neuropathy, tinnitus, hearing impaired, or other neurologic toxicity
Item
Indicate date of neuropathy, tinnitus, hearing impaired, or other neurologic toxicity
date
C0011008 (UMLS CUI [1,1])
C0442874 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2,1])
C0040264 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3,1])
C1384666 (UMLS CUI [3,2])
C0011008 (UMLS CUI [4,1])
C0205394 (UMLS CUI [4,2])
C0205494 (UMLS CUI [4,3])
C0600688 (UMLS CUI [4,4])
Date of acute kidney injury
Item
Indicate date of acute kidney injury
date
C0011008 (UMLS CUI [1,1])
C2609414 (UMLS CUI [1,2])
Date of other complication
Item
Indicate date of other complication
date
C0205394 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item Group
Survival
C1148433 (UMLS CUI-1)
Item
Indicate if death is noted to be directly attributable to lung cancer as indicated on certificate of death
integer
C0007465 (UMLS CUI [1])
C0242379 (UMLS CUI [2])
Cause of death: Death attributable to lung cancer treatment
Code List
Indicate if death is noted to be directly attributable to lung cancer as indicated on certificate of death
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item
Indicate if death was directly attributable to lung cancer treatment
integer
C0007465 (UMLS CUI [1])
C0242379 (UMLS CUI [2,1])
C0920425 (UMLS CUI [2,2])
Cause of death: Death attributable to lung cancer treatment
Code List
Indicate if death was directly attributable to lung cancer treatment
CL Item
No (0)
C1298908 (UMLS CUI-1)
(Comment:en)
CL Item
Yes (1)
C1705108 (UMLS CUI-1)
(Comment:en)
CL Item
Unknown (999)
C0439673 (UMLS CUI-1)
(Comment:en)
Item Group
Quality of death
C0011065 (UMLS CUI-1)
C0332306 (UMLS CUI-2)
Days spent in hospital in the last 30 days of life
Item
Indicate how long patient spent time in the hospital (in hospital includes ICU) at end of life, meaning last 30 days
integer
C3694481 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial